Tidal Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.8M	Buy	57,927 +53,102	+1,101%	+$18.1M	0.06%	377
2025 Q4	$1.92M	Sell	4,825 -2,066	-30%	-$914K	0.01%	968
2025 Q3	$3.14M	Buy	6,891 +1,317	+24%	+$536K	0.01%	722
2025 Q2	$1.82M	Sell	5,574 -553	-9%	-$153K	0.01%	776
2025 Q1	$1.65M	Sell	6,127 -7,061	-54%	-$1.81M	0.01%	774
2024 Q4	$3.1M	Sell	13,188 -7,356	-36%	-$1.93M	0.03%	526
2024 Q3	$5.65M	Buy	20,544 +8,811	+75%	+$2.29M	0.06%	300
2024 Q2	$2.85M	Buy	11,733 +1,452	+14%	+$229K	0.04%	414
2024 Q1	$1.54M	Buy	10,281 +7,660	+292%	+$1.28M	0.03%	661
2023 Q4	$502K	Buy	2,621 +344	+15%	+$58.6K	0.01%	937
2023 Q3	$403K	Buy	2,277 +56	+3%	+$10.7K	0.01%	943
2023 Q2	$422K	Sell	2,221 -1,574	-41%	-$312K	0.01%	903
2023 Q1	$760K	Sell	3,795 -473	-11%	-$99.4K	0.03%	592
2022 Q4	$1.01M	Buy	4,268 +1,827	+75%	+$390K	0.04%	442
2022 Q3	$489K	Buy	2,441 +633	+35%	+$121K	0.02%	574
2022 Q2	$264K	Sell	1,808 -595	-25%	-$84.4K	0.01%	829
2022 Q1	$392K	Buy	2,403 +222	+10%	+$33.8K	0.01%	733
2021 Q4	$370K	Sell	2,181 -193	-8%	-$35.9K	0.01%	705
2021 Q3	$448K	Buy	2,374 +373	+19%	+$70K	0.02%	540
2021 Q2	$339K	Buy	+2,001	New	+$293K	0.01%	534